Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azilsartan in Pediatric Patients with Hypertension
NCT02791438Phase 3Completed
- Sponsor
- Takeda
- Start
- Aug 2016
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of azilsartan in hypertension (HTN) (2 arms), sponsored by Takeda. Primary endpoints: Number of Participants Reporting One or More Treatment-emergent Adverse Events, Number of Participants With TEAEs Related to Anthropometric Measurement and 3 more. Started Aug 2016; status: completed.
02
Drugs
azilsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02791438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02791438.